S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000

Completed · Phase 3 · Has a placebo group

Conditions studied: Cataract, Macular Degeneration

In brief

RATIONALE: Aging may affect a person's vision. Vitamin E and/or selenium may help prevent cataracts or age-related macular degeneration in men receiving these drugs as part of a clinical trial for the prevention of prostate cancer. PURPOSE: This clinical trial is studying vitamin E and/or selenium to see how well they work in preventing cataract and age-related macular degeneration in men enrolled on SELECT (SWOG-S0000).

Key facts

Study ID

NCT00784225

Run by

SWOG Cancer Research Network

People needed

13475

Starts

2004-07-01

Expected to finish

2018-05-01

Last updated by the study team

2019-08-14

Who can join

Age: 50 and older, up to 120. Sex: male. Healthy volunteers: accepted.

Where it is running

• Harvard Medical School — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.